Radiopharmaceuticals for diagnosing Alzheimer's disease

US6872381B1 · kind B1 · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Christoph-Stephan Hilger · Berlin, DE
• Bernd Johannsen · Dresden, DE
• Joerg Steinbach · Bischofswerda, DE
• Peter Maeding · Dresden, DE
• Meredith Halks-Miller · Woodside, US
• Richard Horuk · Belmont, US
• Harald Dinter · San Rafael, US
• Raju Mohan · Encinitas, US
• Joseph E. Hesselgesser · San Francisco, US

Key dates

• Filing date: Jul 25, 2003
• Grant date: Mar 29, 2005
• Expiry date: Jul 25, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/05
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention is directed to the use of radiopharmaceuticals in diagnosing Alzheimer's disease. In particular the radiopharmaceuticals of the invention are able to pass through the blood-brain barrier and bind to the CCR1 receptor present in brain tissue of patients having Alzheimer's disease.